Molecular diagnostics firm BillionToOne raised $314 million in the DNA test maker’s upsized initial public offering but saw ...

For decades, it was impossible for clinicians to know which babies with major heart defects might eventually have ...

Nearly every woman who gives birth in an American hospital is strapped with a belt of sensors to track the baby’s heartbeat. If the pattern is deemed abnormal — too slow, for example — doctors often ...

Gestational surrogacy is never a solo act. The medical, legal, and emotional layers are real, which is exactly why building ...

Until recently, it was not uncommon for Dr. Jeannie Kelly, a high risk obstetrician at Washington University School of ...

The hospital has continued to see growth in scans at multiple locations – meaning it is holistically seeing more patients who ...

People who very much want to become pregnant could soon find their right to procreate restricted by criminal anti-abortion ...

AI is most effective when paired with human judgment, integrated into workflows and measured not in algorithms but in lives saved.

Guardant Health, Inc. , a leading precision oncology company, today announced the expansion of its Guardant Reveal® blood test to include late-stage therapy response monitoring for patients with solid ...

For one art-drenched week in late October, the Institute of Management and Technology Enugu's International Conference Centre gives itself over to its annual rendezvous. LIMCAF -- that irrepressible ...

The standard of care in cancer, adopted in the 1990s, is built on consensus based clinical research over large patient populations. However, if we know biologically each person is unique, then a ...